Supreme Court upholds Tennessee ban on transgender youth medical care

Supreme Court upholds Tennessee ban on transgender youth medical care


People hold rainbow-coloured umbrellas and flags at a demonstration as the U.S. Supreme Court hears arguments over an appeal by U.S. President Joe Biden’s administration of a lower court’s decision upholding a Republican-backed ban in Tennessee on gender-affirming medical care for transgender minors, outside the court in Washington, U.S., December 4, 2024. 

Benoit Tessier | Reuters

The Supreme Court on Wednesday upheld a Tennessee law restricting gender transition care for minors, delivering a major blow to transgender rights.

The 6-3 ruling is likely to have a broad impact as 24 other states have already enacted laws similar to the one in Tennessee, which bars gender transition surgery, puberty blockers and hormone therapy.

Those laws now look set to survive similar legal challenges. The ruling does not affect states that do not have such bans, meaning care in those states will still be available.

The court in an opinion authored by Chief Justice John Roberts concluded that the Tennessee law does not constitute a form of sex discrimination that would violate the Constitution’s 14th Amendment.

Trans rights activists have also warned that a ruling allowing bans on care for trans minors could pave the way for similar restrictions aimed at adults.

The legal challenge was brought by the administration of former President Joe Biden as well as transgender teens and their families.

The ruling does not definitely resolve all legal issues relating to the state bans as it did not address a separate argument under the 14th Amendment that the laws violate the right of parents to make health care decisions for their children.

Upon taking office in January, President Donald Trump has set about unwinding Biden policies that sought to bolster transgender rights. Among other things, he signed an executive order seeking to restrict gender-affirming care for teens nationwide A judge quickly blocked it.

Trump has also imposed new restrictions on transgender people serving in the military.

Upon taking office in January, President Donald Trump has set about unwinding Biden policies that sought to bolster transgender rights. Among other things, he signed an executive order seeking to restrict gender-affirming care for teens nationwide. A judge quickly blocked it.

Trump has also imposed new restrictions on transgender people serving in the military.

Enacted in 2023, the Tennessee law is among a wave of similar measures taken by states imposing restrictions on gender transition treatments. In defending its ban, the state’s lawyers pointed to similar measures taken in other countries, including in Europe.

Tennessee Attorney General Jonathan Skrmetti emphasized in court papers the evolving debate over how best to treat minors diagnosed with gender dysphoria, the clinical term given to the distress people can experience when their gender identities are in conflict with the genders assigned to them at birth.

Major medical organizations say gender-affirming treatments are an effective way to treat gender dysphoria.

The challengers argued that the law is a form of sex discrimination that violates the 14th Amendment’s equal protection clause because the treatments at issue in the case — puberty blockers and hormone therapy — can be used in other situations.

The case marks the most significant ruling on transgender rights since the court in 2020, to the surprise of many, ruled that federal employment protections extend to gender identity as well as sexual orientation.

The dispute reached the Supreme Court after the Cincinnati-based 6th U.S. Circuit Court of Appeals in 2023 rejected challenges to the Tennessee law and a similar measure in Kentucky.

A district court judge had blocked parts of the law, while concluding that plaintiffs did not have legal standing to challenge the surgery ban. That provision of the law was not at issue before the Supreme Court.



Source

FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option
Health

FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option

The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV – a milestone that the company and some experts say could help bring the world closer to ending the decades-long epidemic […]

Read More
CEO of Sean Parker’s breakthrough cancer drug institute on leading new race for cure
Health

CEO of Sean Parker’s breakthrough cancer drug institute on leading new race for cure

Karen Knudsen did not grow up in a scientifically centered home. She grew up in a military family. But at an early age, as a “naturally curious” kid, she came to love the experience of discovery and gravitated toward math and science. That led Knudsen to assume she would one day become a medical doctor. […]

Read More
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump’s plan
Health

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump’s plan

The Johnson & Johnson logo displayed on a monitor. Sopa Images | Lightrocket | Getty Images Two Democratic lawmakers on Tuesday pressed five of the nation’s largest pharmaceutical companies about their low tax bills and whether they support extending massive tax cuts for the industry in the GOP reconciliation bill. Sen. Elizabeth Warren, D-Mass., and […]

Read More